BetterLife Pharma (STU:NPAU) EBIT per Share : €-0.02 (TTM As of Jan. 2024)

View and export this data going back to 2018. Start your Free Trial

What is BetterLife Pharma EBIT per Share?

BetterLife Pharma's EBIT per Share for the three months ended in Jan. 2024 was €-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2024 was €-0.02.

During the past 3 years, the average EBIT per Share Growth Rate was 53.80% per year. During the past 5 years, the average EBIT per Share Growth Rate was 46.80% per year. During the past 10 years, the average EBIT per Share Growth Rate was 1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for BetterLife Pharma's EBIT per Share or its related term are showing as below:

STU:NPAU' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -618.4 Med: 26.9 Max: 53.8
Current: 53.8

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of BetterLife Pharma was 53.80% per year. The lowest was -618.40% per year. And the median was 26.90% per year.

STU:NPAU's 3-Year EBIT Growth Rate is ranked better than
94.25% of 1305 companies
in the Biotechnology industry
Industry Median: 3.5 vs STU:NPAU: 53.80

BetterLife Pharma's EBIT for the three months ended in Jan. 2024 was €-0.45 Mil.

BetterLife Pharma EBIT per Share Historical Data

The historical data trend for BetterLife Pharma's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BetterLife Pharma EBIT per Share Chart

BetterLife Pharma Annual Data

Trend

Jan15

Jan16

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Jan24

EBIT per Share

Get a 7-Day Free Trial

-0.88

-0.87

-0.11

-0.07

-0.02

BetterLife Pharma Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EBIT per Share	Get a 7-Day Free Trial															-	-0.01	-0.01	-	-

BetterLife Pharma EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

BetterLife Pharma's EBIT per Share for the fiscal year that ended in Jan. 2024 is calculated as

	EBIT per Share		(A: Jan. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-1.948	/	109.286
=	-0.02

BetterLife Pharma's EBIT per Share for the quarter that ended in Jan. 2024 is calculated as

	EBIT per Share		(Q: Jan. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.449	/	114.910
=	-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.02

BetterLife Pharma (STU:NPAU) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

BetterLife Pharma EBIT per Share Related Terms

Thank you for viewing the detailed overview of BetterLife Pharma's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

BetterLife Pharma (STU:NPAU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BetterLife Pharma Inc (STU:NPAU) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

BETRF:USA NPAU:Germany BETR:Canada

Address

1275 West 6th Avenue, Suite 300, Vancouver, BC, CAN, V6H 1A6

Website

https://www.abetterlifepharma.com

BetterLife Pharma Inc a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumors to treat various types of cancer.

BetterLife Pharma (STU:NPAU) Headlines

No Headlines